Based on 2 analysts offering 12 month price targets for Vicore Pharma Holding Ab
Min Forecast
$15.00+59.4%
Avg Forecast
$20.00+112.54%
Max Forecast
$25.00+165.67%
Should I buy or sell VCRE stock?
Based on 2 analysts offering ratings for Vicore Pharma Holding Ab.
Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although VCRE's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates VCRE as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More
Be the first to know when Wall Street analysts revise their VCRE stock forecasts and price targets.
Is Vicore Pharma Holding Ab Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: VCRE) stock is to Strong Buy VCRE stock.
Out of 2 analysts, 2 (100%) are recommending VCRE as a Strong Buy, 0 (0%) are recommending VCRE as a Buy, 0 (0%) are recommending VCRE as a Hold, 0 (0%) are recommending VCRE as a Sell, and 0 (0%) are recommending VCRE as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year VCRE price target, the average VCRE price target is $20.00, with the highest VCRE stock price forecast at $25.00 and the lowest VCRE stock price forecast at $15.00.
On average, Wall Street analysts predict that Vicore Pharma Holding Ab's share price could reach $20.00 by Nov 4, 2027. The average Vicore Pharma Holding Ab stock price prediction forecasts a potential upside of 112.54% from the current VCRE share price of $9.41.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.